Tocotrienols are good adjuvants for developing cancer vaccines

BackgroundDendritic cells (DCs) have the potential for cancer immunotherapy due to their ability to process and present antigens to T-cells and also in stimulating immune responses. However, DC-based vaccines have only exhibited minimal effectiveness against established tumours in mice and humans. The use of appropriate adjuvant enhances the efficacy of DC based cancer vaccines in treating tumours.MethodsIn this study we have used tocotrienol-rich fraction (TRF), a non-toxic natural compound, as an adjuvant to enhance the effectiveness of DC vaccines in treating mouse mammary cancers. In the mouse model, six-week-old female BALB/c mice were injected subcutaneously with DC and supplemented with oral TRF daily (DC+TRF) and DC pulsed with tumour lysate from 4T1 cells (DC+TL). Experimental mice were also injected with DC pulsed with tumour lysate and supplemented daily with oral TRF (DC+TL+TRF) while two groups of animal which were supplemented daily with carrier oil (control) and with TRF (TRF). After three times vaccination, mice were inoculated with 4T1 cells in the mammary breast pad to induce tumour.ResultsOur study showed that TRF in combination with DC pulsed with tumour lysate (DC+TL+TRF) injected subcutaneously significantly inhibited the growth of 4T1 mammary tumour cells as compared to control group. Analysis of cytokines production from murine splenocytes showed significant increased productions of IFN-γ and IL-12 in experimental mice (DC+TL+TRF) compared to control, mice injected with DC without TRF, mice injected with DC pulsed with tumour lysate and mice supplemented with TRF alone. Higher numbers of cytotoxic T cells (CD8) and natural killer cells (NK) were observed in the peripheral blood of TRF adjuvanted DC pulsed tumour lysate mice.ConclusionOur study show that TRF has the potential to be an adjuvant to augment DC based immunotherapy.

• Publication year

  2010

• Venue

  BMC Cancer

• Publication date

  2010-01-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1186/1471-2407-10-5PMID 20051142PMCID 2824713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural-killer cells and dendritic cells: "l'union fait la force".

  2005cited by this paper
• Chemo-Immunotherapy of Breast Cancer Using Vesiculated α-Tocopheryl Succinate in Combination With Dendritic Cell Vaccination

  2005cited by this paper
• Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice

  2004cited by this paper
• Disruption of mitochondria during tocotrienol-induced apoptosis in MDA-MB-231 human breast cancer cells.

  2004cited by this paper
• Tocotrienol‐Rich Fraction from Palm Oil and Gene Expression in Human Breast Cancer Cells

  2004cited by this paper
• Bacterial Probiotic Modulation of Dendritic Cells

  2004cited by this paper
• Activation, Differentiation, and Migration of Naive Virus-Specific CD8+ T Cells during Pulmonary Influenza Virus Infection1

  2004cited by this paper
• α-Tocopheryl succinate sensitizes established tumors to vaccination with nonmatured dendritic cells

  2004cited by this paper
• A novel tumor-vaccine cell therapy using bone marrow-derived dendritic cell type 1 and antigen-specific Th1 cells.

  2003cited by this paper
• Activation of the Murine Interleukin-12 p40 Promoter by Functional Interactions between NFAT and ICSBP*

  2003cited by this paper
• Cutting Edge: Rapid In Vivo Killing by Memory CD8 T Cells1

  2003cited by this paper
• α-Tocopheryl Succinate, the Most Effective Form of Vitamin E for Adjuvant Cancer Treatment: A Review

  2003cited by this paper
• BMC Cancer

  2003cited by this paper
• Comparative analysis of IFN-gamma B7.1 and antisense TGF-beta gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma.

  2001cited by this paper
• Human papillomavirus DNA in plasma of patients with cervical cancer

  2001cited by this paper
• Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents.

  2001cited by this paper
• Comparative analysis of IFN-γ B7.1 and antisense TGF-β gene transfer on the tumorigenicity of a poorly immunogenic metastatic mammary carcinoma

  2001cited by this paper
• NK- and CD8+ T Cell-Mediated Eradication of Established Tumors by Peritumoral Injection of CpG-Containing Oligodeoxynucleotides1

  2001cited by this paper
• Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor.

  2001cited by this paper
• Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model.

  2000cited by this paper
• Tocotrienols inhibit growth of ZR-75–1 breast cancer cells

  2000cited by this paper
• Systemic administration of interleukin 2 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines.

  1999cited by this paper
• Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status

  1998cited by this paper
• Abundant microsatellite polymorphism in Saccharomyces cerevisiae, and the different distributions of microsatellites in eight prokaryotes and S. cerevisiae, result from strong mutation pressures and a variety of selective forces.

  1998cited by this paper
• Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo.

  1998cited by this paper
• IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages.

  1997cited by this paper
• Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells by palm oil tocotrienols and tamoxifen, alone and in combination.

  1997cited by this paper
• Presentation of exogenous protein antigens on major histocompatibility complex class I molecules by dendritic cells: pathway of presentation and regulation by cytokines.

  1997cited by this paper
• Dendritic Cells as Adjuvants for Immune-mediated Resistance to Tumors

  1997cited by this paper
• Induction of antitumor immunity using bone marrow-generated dendritic cells.

  1996cited by this paper
• Effect of tocotrienols on the growth of a human breast cancer cell line in culture

  1995cited by this paper
• The dendritic cell system and its role in immunogenicity.

  1991cited by this paper

• Daily Supplementation of High Doses of Tocotrienol-Rich Fraction From Palm Oil Produced No Toxic Effects in Healthy Mice

  2025cites this paper
• Delineating the Immunotherapeutic Potential of Vitamin E and Its Analogues in Cancer: A Comprehensive Narrative Review

  2024cites this paper
• Revisiting the therapeutic potential of tocotrienol

  2022cites this paper
• Chemopreventive and anti-tumor potential of vitamin E in preclinical breast cancer studies: A systematic review.

  2022cites this paper
• PALM GAMMA-TOCOTRIENOL SUPPLEMENTATION SUPPRESS TUMOUR GROWTH AND METASTASIS IN A SYNGENEIC MOUSE MODEL OF BREAST CANCER

  2021cites this paper
• ELUCIDATING THE ROLE OF THE SATB1 GENE IN BREAST CANCER CARCINOGENESIS IN THE PRESENCE OR ABSENCE OF TOCOTRIENOL-RICH FRACTION: EVIDENCE FROM A SYNGENEIC MOUSE MODEL OF BREAST CANCER

  2021cites this paper
• Tocotrienol-rich Fraction Modulated Genes Responsible for Inflammation in Lipopolysaccharide-stimulated RAW 264.7 Macrophages

  2021cites this paper
• Reduced infiltration of regulatory T cells in tumours from mice fed daily with gamma‐tocotrienol supplementation

  2021cites this paper
• Palm Tocotrienol-Adjuvanted Dendritic Cells Decrease Expression of the SATB1 Gene in Murine Breast Cancer Cells and Tissues

  2019cites this paper
• The Anti-inflammatory Effects of Tocotrienol in Macrophages

  2019cites this paper
• Bioactive Compounds: Natural Defense Against Cancer?

  2019cites this paper
• Zein-polysaccharide nanoparticles as matrices for antioxidant compounds: A strategy for prevention of chronic degenerative diseases.

  2018cites this paper
• Consensus statement for cancer patients requiring intensive care support

  2018cites this paper
• Concurrent chemoradiation therapy tailored to the older adults with esophageal cancer: state of the art and the future

  2018cites this paper
• Tocotrienols and Acute Myeloid Leukaemia

  2018cites this paper
• Tocotrienol Rich Fraction Supplementation Modulate Brain Hippocampal Gene Expression in APPswe/PS1dE9 Alzheimer’s Disease Mouse Model

  2018cites this paper
• Teaser Vitamin E is a lipid-soluble , radical buster existing in two different isoforms : tocotrienols and tocopherols

  2017cites this paper
• Tocotrienols: the unsaturated sidekick shifting new paradigms in vitamin E therapeutics.

  2017cites this paper
• Tocotrienol-Rich Fraction Supplementation Modulates Antioxidant Enzymes Activity and Reduces DNA Damage in APPswe/PS1dE9 Alzheimer's Disease Mouse Model (Suplementasi Fraksi Kaya Tokotrienol Memodulasi Aktiviti Enzim Antioksidan dan Mengurangkan Kerosakan DNA pada APPswe/PS1dE9 Model Mencit Penyakit

  2016cites this paper
• Recombinant Caseous Lymphadenitis Vaccine with Palm Oil as Adjuvant Enhances the Humoral and Cell-Mediated Immune Responses in Rat Model

  2016cites this paper
• Autophagy inhibitor 3-methyladenine potentiates apoptosis induced by dietary tocotrienols in breast cancer cells

  2015cites this paper
• Efeito protetor in vivo de vacinas de células dendríticas sensibilizadas com RNA de células MC-38 pré-tratadas com agentes antineoplásticos em concentrações efetivas minímas

  2014cites this paper
• Research advancements in palm oil nutrition

  2014cites this paper
• Monitoring and Targeting of Myeloid-Derived Suppressor Cells (MDSC) in Different Mouse Cancer Models

  2014cites this paper
• Bioavailability of tocotrienols: evidence in human studies

  2014cites this paper
• Vitamin E d-Tocotrienol Prolongs Survival in the LSL-KrasG 12 D / þ ; LSL-Trp 53 R 172 H / þ ; Pdx-1-Cre ( KPC ) Transgenic Mouse Model of Pancreatic Cancer

  2013cites this paper
• (KPC) transgenic mouse model of pancreatic cancer

  2013cites this paper
• Vitamin E δ-Tocotrienol Prolongs Survival in the LSL-KrasG12D/+;LSL-Trp53R172H/+;Pdx-1-Cre (KPC) Transgenic Mouse Model of Pancreatic Cancer

  2013cites this paper
• Extraction and Purification of Gamma-Tocotrienol from Rice Bran Oil Deodorizer Distillate

  2013cites this paper
• Transgenic Mouse Model of Pancreatic Cancer

  2013cites this paper
• Vitamin E Family of Compounds and Cancer Prevention

  2013cites this paper
• Tocotrienol-Adjuvanted Dendritic Cells Inhibit Tumor Growth and Metastasis: A Murine Model of Breast Cancer

  2013cites this paper
• The Natural Killer Cell: A Historical Perspective and the Use of Supplements to Enhance NKC Activity

  2012cites this paper
• Mechanism of Delta‑Tocotrienol on Colorectal Cancer

  2012cites this paper
• Breast Cancer Proteome Takes More Than Two to Tango on TRAIL: Beat Them at Their Own Game

  2012cites this paper
• Tocotrienol as a potential anticancer agent.

  2012cites this paper
• Advances in immunotherapy using dendritic cells

  2012cites this paper
• Tocotrienols and breast cancer: the evidence to date

  2011cites this paper
• Evaluation of the immunomodulatory effect of the 14 kDa protein isolated from aged garlic extract on dendritic cells.

  2011cites this paper
• Why tocotrienols work better: insights into the in vitro anti-cancer mechanism of vitamin E

  2011cites this paper
• Tocotrienols, the vitamin E of the 21st century: its potential against cancer and other chronic diseases.

  2010cites this paper
• Inflammation, aging, and cancer vaccines

  2010cites this paper